MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more
MicroPort CardioFlow Medtech Corporation (MROPF) - Total Liabilities
Latest total liabilities as of June 2025: $450.55 Million USD
Based on the latest financial reports, MicroPort CardioFlow Medtech Corporation (MROPF) has total liabilities worth $450.55 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MicroPort CardioFlow Medtech Corporation - Total Liabilities Trend (2020–2024)
This chart illustrates how MicroPort CardioFlow Medtech Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MicroPort CardioFlow Medtech Corporation Competitors by Total Liabilities
The table below lists competitors of MicroPort CardioFlow Medtech Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
USA | $1.82 Billion |
|
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898
|
China | CN¥337.07 Million |
|
Orthocell Ltd
AU:OCC
|
Australia | AU$20.67 Million |
|
Syscom Computer Engineering Co
TW:2453
|
Taiwan | NT$2.76 Billion |
|
X-Legend Entertainment Co Ltd
TW:4994
|
Taiwan | NT$297.82 Million |
|
icad inc
NASDAQ:ICAD
|
USA | $8.68 Million |
|
Asia Paper
KO:002310
|
Korea | ₩201.31 Billion |
|
ASolid Technology Co Ltd
TWO:6485
|
Taiwan | NT$307.30 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down MicroPort CardioFlow Medtech Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MicroPort CardioFlow Medtech Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MicroPort CardioFlow Medtech Corporation (2020–2024)
The table below shows the annual total liabilities of MicroPort CardioFlow Medtech Corporation from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $454.07 Million | +87.44% |
| 2023-12-31 | $242.25 Million | -2.14% |
| 2022-12-31 | $247.55 Million | -6.77% |
| 2021-12-31 | $265.52 Million | -81.78% |
| 2020-12-31 | $1.46 Billion | -- |